Current Clinical Trials

Name	Treatment	Number of patients	Enrollment Status
Phase II/III Randomized, Placebo-Controlled Trial of Arimoclomol in SOD1 Positive Familial ALS	Arimoclomol	80	Recruiting
Clinical Trial Ceftriaxone in Subjects With ALS	Ceftriaxone	600	Recruiting
Cistanche Total Glycosides for Amyotrophic Lateral Sclerosis: A Randomized Control Trial (RCT) Study Assessing Clinical Response	Cistanche Total Glycosides	40	Recruiting
Combination Therapy Selection Trial in Amyotrophic Lateral Sclerosis	Creatine & COX-2 inhibitors combined	120	Recruiting
A Phase II/III Study in Patients with Amyotrophic Lateral Sclerosis	E0302	300	Recruiting
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)	Edaravone	200	Recruiting
The Effect of Intensive Controlled Exercise in the Early Stages of Amyotrophic Lateral Sclerosis	Exercise	20	Recruiting
Far Infrared Irradiation for Control, Management and Treatment of Amyotrophic Lateral Sclerosis	Far Infrared Irradiation	10	Ongoing bu not Recruiting
A Multi-Centered Controlled Screening Trial of Safety and Efficacy of Lithium Carbonate in Subjects With Amyotrophic Lateral Sclerosis	Lithium	100	Recruiting
Study to Investigate the Safety and Efficacy of Lithium in Volunteers with ALS	Lithium	250	Recruiting
Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS)	Memantine	60	Recruiting
The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in ALS	Memantine	0	42
Study of Pioglitazone in Parients with ALS	Pioglitazone	220	Recruiting
Safety and Tolerability Study of KNS-760704 in Amyotrophic Lateral Sclerosis	R(+) Pramipexole	102	Not Recruiting
Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis	SB-509	40	Recruiting
Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis	Sodium Valproate	173	Recruiting
Talampanel for Amyotrophic Lateral Sclerosis (ALS)	Talampanel	540	currently recruiting
Phase II Study Using Thalidomide for the Treatment of ALS	Thalidomide	24	Recruiting
Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS)	Thalidomide	40	Recruiting
A Sefety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients with Amyotrophic Lateral Sclerosis	VEGF	28	Recruiting